2011
DOI: 10.1053/j.ackd.2010.10.003
|View full text |Cite
|
Sign up to set email alerts
|

Hypertension in Diabetic Nephropathy: Epidemiology, Mechanisms, and Management

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
114
2
10

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 188 publications
(129 citation statements)
references
References 94 publications
3
114
2
10
Order By: Relevance
“…Considering the high frequency of hypertension and severe proteinuria in our nephropathy patients, and their associations with preterm delivery, it is possible that intensified control of BP levels starting from early pregnancy could improve outcomes [7,16,40]. Aggressive treatment with up to four antihypertensive drugs may be required to reach target levels, due to long-term haemodynamic alterations, such as increased peripheral vasoconstriction [13,16,41]. Baseline assessments of proteinuria and kidney function should be performed before or in early pregnancy in parturients with diabetes to identify those with need for strict antihypertensive control.…”
Section: Discussionmentioning
confidence: 99%
“…Considering the high frequency of hypertension and severe proteinuria in our nephropathy patients, and their associations with preterm delivery, it is possible that intensified control of BP levels starting from early pregnancy could improve outcomes [7,16,40]. Aggressive treatment with up to four antihypertensive drugs may be required to reach target levels, due to long-term haemodynamic alterations, such as increased peripheral vasoconstriction [13,16,41]. Baseline assessments of proteinuria and kidney function should be performed before or in early pregnancy in parturients with diabetes to identify those with need for strict antihypertensive control.…”
Section: Discussionmentioning
confidence: 99%
“…Although RAS activation may contribute to the progression of diabetic nephropathy, the mechanism of this pathology is incompletely understood (Van Buren & Toto, 2011). Interestingly, ERK1/2 phosphorylation observed in diabetic nephropathy could be explained by succinateactivated SUCNR1 in the renal tubules of diabetic mice (Robben et al, 2009).…”
Section: Diabetes and Obesitymentioning
confidence: 99%
“…12 Por outro lado, é consenso que a busca do controle pressórico ultrapassa discussões relativas a diferentes classes de drogas. Dito de outra maneira, não cabe discutir o benefício de determinada classe de droga sem que antes se assegure o controle pressórico rigoroso nos pacientes diabéticos hipertensos.…”
Section: Controle Pressóricounclassified